Jupiter Neurosciences, Inc. (JUNS)
3.06
-0.03
(-0.97%)
USD |
NASDAQ |
Sep 10, 16:00
3.08
+0.02
(+0.65%)
After-Hours: 20:00
Jupiter Neurosciences Enterprise Value : 2.308M for Sept. 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 2.308M |
| September 08, 2026 | 2.301M |
| September 04, 2026 | 2.434M |
| September 03, 2026 | 2.421M |
| September 02, 2026 | 2.534M |
| September 01, 2026 | 2.480M |
| August 31, 2026 | 2.607M |
| August 28, 2026 | 3.032M |
| August 27, 2026 | 3.504M |
| August 26, 2026 | 3.584M |
| August 25, 2026 | 3.690M |
| August 24, 2026 | 4.016M |
| August 21, 2026 | 4.375M |
| August 20, 2026 | 3.690M |
| August 19, 2026 | 3.444M |
| August 18, 2026 | 3.617M |
| August 17, 2026 | 3.697M |
| August 14, 2026 | 3.737M |
| August 13, 2026 | 4.242M |
| August 12, 2026 | 3.318M |
| August 11, 2026 | 3.378M |
| August 10, 2026 | 3.783M |
| August 07, 2026 | 3.644M |
| August 06, 2026 | 3.998M |
| August 05, 2026 | 4.092M |
| Date | Value |
|---|---|
| August 04, 2026 | 5.419M |
| August 03, 2026 | 5.239M |
| July 31, 2026 | 4.741M |
| July 30, 2026 | 5.114M |
| July 29, 2026 | 5.189M |
| July 28, 2026 | 5.723M |
| July 27, 2026 | 5.912M |
| July 24, 2026 | 6.286M |
| July 23, 2026 | 7.881M |
| July 22, 2026 | 8.958M |
| July 21, 2026 | 8.714M |
| July 20, 2026 | 8.480M |
| July 17, 2026 | 8.854M |
| July 16, 2026 | 8.928M |
| July 15, 2026 | 9.153M |
| July 14, 2026 | 9.128M |
| July 13, 2026 | 9.312M |
| July 10, 2026 | 9.721M |
| July 09, 2026 | 10.03M |
| July 08, 2026 | 9.866M |
| July 07, 2026 | 11.01M |
| July 06, 2026 | 11.28M |
| July 02, 2026 | 11.37M |
| July 01, 2026 | 10.97M |
| June 30, 2026 | 10.93M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 671.47B |
| Jaguar Health, Inc. | 11.80M |
| Atai Beckley, Inc. | 2.468B |
| ANI Pharmaceuticals, Inc. | 1.859B |
| Corcept Therapeutics, Inc. | 12.19B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.274M |
| Revenue (Quarterly) | 0.0242M |
| Total Expenses (Quarterly) | 2.299M |
| EPS Diluted (Quarterly) | -4.079 |
| Gross Profit Margin (Quarterly) | 87.19% |
| Profit Margin (Quarterly) | -9.40K% |
| Earnings Yield | -624.6% |
| Normalized Earnings Yield | -661.25 |